Twenty-year survival of gastric cancer with peritoneal metastases using long-term normothermic intraperitoneal 5-fluorouracil and systemic mitomycin C: A case report.

MedStar author(s):
Citation: International Journal of Surgery Case Reports. 2019 Jul 12PMID: 31399397Institution: Washington Cancer InstituteForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: IN PROCESS -- NOT YET INDEXEDYear: 2019ISSN:
  • 2210-2612
Name of journal: International journal of surgery case reportsAbstract: BACKGROUND: Primary gastric cancer that presents with peritoneal metastases has few options for successful treatment.CONCLUSIONS: Gastric cancer with peritoneal metastases was successfully treated with a combination of gastrectomy plus intraperitoneal and systemic chemotherapy. Further studies using this simplified approach may be indicated.Copyright (c) 2019. Published by Elsevier Ltd.METHODS: A simplified treatment plan started with total gastrectomy and hyperthermic intraperitoneal chemotherapy. After placement of an intraperitoneal port combined intraperitoneal and systemic chemotherapy was given for six months.RESULTS: The treatments were tolerated well and associated with an acceptable quality of life and no adverse events. The patient is a 20-year survivor of her disease.All authors: Sugarbaker PHFiscal year: FY2020Digital Object Identifier: Date added to catalog: 2019-08-27
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 31399397 Available 31399397

BACKGROUND: Primary gastric cancer that presents with peritoneal metastases has few options for successful treatment.

CONCLUSIONS: Gastric cancer with peritoneal metastases was successfully treated with a combination of gastrectomy plus intraperitoneal and systemic chemotherapy. Further studies using this simplified approach may be indicated.

Copyright (c) 2019. Published by Elsevier Ltd.

METHODS: A simplified treatment plan started with total gastrectomy and hyperthermic intraperitoneal chemotherapy. After placement of an intraperitoneal port combined intraperitoneal and systemic chemotherapy was given for six months.

RESULTS: The treatments were tolerated well and associated with an acceptable quality of life and no adverse events. The patient is a 20-year survivor of her disease.

English

Powered by Koha